Revisiting emerging infectious diseases: The unfinished agenda

Journal of Community Health

Volumn 26, Issue 2, 2001, Pages 113-122

  Kombe, Gilbert C ^a   Darrow, Danielle M ^b  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b George Washington Center for Integrative Medicine   (United States)

Author keywords

Disease impact on development; Epidemiology new and emerging infectious disease; Infectious disease; International public health

Indexed keywords

ANTIBIOTIC RESISTANCE; CLASSIFICATION; COMMUNICABLE DISEASE; DISEASE TRANSMISSION; HEALTH; HUMAN; INFECTION CONTROL; PUBLIC HEALTH SERVICE; REVIEW; SOCIOECONOMICS;

COMMUNICABLE DISEASE CONTROL; COMMUNICABLE DISEASES, EMERGING; DRUG RESISTANCE, MICROBIAL; HUMANS; PUBLIC HEALTH PRACTICE; SOCIOECONOMIC FACTORS; WORLD HEALTH;

EID: 0035315980     PISSN: 00945145     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005277213366     Document Type: Article

References (19)

1. Institute of Medicine (IOM). Emerging Infections: Microbial Threats to Health in the United States. Washington, DC: National Academy Press, 1994.
2. World Health Organization (WHO). The World Health Report 1998. Geneva: WHO, 1998, p. 44.
3. Joint United Nations Programme on HIV/AIDS (UNAIDS). Report on the Global HIV/AIDS Epidemic. Geneva: UNAIDS, 2000.
4. UNAIDS. A Review of Household and Community Responses to the HIV/AIDS Epidemic in the Rural Areas of Sub-Saharan Africa. Geneva: UNAIDS, 1999.
5. Silverstein, K. Millions for Viagra, Pennies for Diseases of the Poor. The Nation July 19, 1999, p. 5.
6. Raviglione, MC, Dye, C, Schmidt, S, and Koch, A. Assessment of Worldwide Tuberculosis Control. Lancet 1997; 350:624-629.
7. Dye, C. Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country. JAMA 1999; 19:282,7.
8. WHO, Division of Control of Tropical Diseases. Malaria Control and Prevention. Online: www.who.int/ctd/html/malaria.html.
9. WHO. Tuberculosis Handbook. Geneva: WHO, 1998, p. 10.
10. Nyonator, F and Kutzin, J. Health for some? The Effects of User Fees in the Volta Region of Ghana. Health Policy and Planning 1999; 14(4):329-341.
11. WHO. Antimicrobial Resistance. Factsheet No. 194. 1998. Online: www.who.int/inf-fs/en/fact194.html.
12. National Tuberculosis and Lung Disease Research Institute Report, 1998 (unpublished).
13. Harrison, PF and Lederber, J. (Eds). Antimicrobial Resistance: Issues and Options. Proceedings from the Forum on Emerging Infections, Washington, DC: Institute of Medicine (IOM), 1998.
14. Okie, S. TB Fights Back. The Washington Post August 17, 1999, p. Z10.
15. Sachs, J. Sachs on Development: Helping the World's Poorest. The Economist 1999; 353(8132): 17-20.
16. World Trade Organization (WTO). Online: www.wto.org/wto/intellec/1-ipcon.htm.
17. Section 5, Articles 6 and 31 of TRIPS most directly address these issues.
18. Bond, P. Globalization, Pharmaceutical Pricing and South African Health Policy: Managing Confrontation with U.S. Firms and Politicians. Int J Hlth Sci 1999; 29:4.
19. Weissman, R. AIDS and Developing Countries: Democratizing Access to Essential Medicines. Foreign Policy In Focus 1999; 4:23.